Global E-Clinical Solutions Market

1 INTRODUCTION OF GLOBAL E-CLINICAL SOLUTIONSMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources

4 GLOBAL E-CLINICAL SOLUTIONSMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework

5 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY END USER:
5.1 Pharmaceutical and Biopharmaceutical Companies
5.2 Contract Research Organizations
5.3 Consulting Service Companies
5.4 Medical Device Manufacturers
5.5 Hospitals
5.6 Academic Research Institutes

6 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE:
6.1 Phase I Clinical Trials
6.2 Phase II Clinical Trials
6.3 Phase III Clinical Trials
6.4 Phase IV Clinical Trials

7 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE:
7.1 Web-Hosted (On-Demand) Solutions
7.2 Licensed Enterprise (On-Premise) Solutions
7.3 Cloud-Based (SaaS) Solutions

8 GLOBAL E-CLINICAL SOLUTIONS MARKET, BY PRODUCT:
8.1 Electronic Data Capture and Clinical Data Management Systems
8.2 Clinical Trial Management Systems
8.3 Clinical Analytics Platforms
8.4 Randomization and Trial Supply Management
8.5 Clinical Data Integration Platforms
8.6 Electronic Clinical Outcome Assessment Solutions
8.7 Safety Solutions
8.8 Electronic Trial Master File Systems
8.9 Regulatory Information Management Solutions
8.10 Other Eclinical Solutions

9 GLOBAL E-CLINICAL SOLUTIONSMARKET, BY GEOGRAPHY
9.1 Overview
9.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.2.1 U.S.
9.2.2 Canada
9.2.3 Mexico
9.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
9.3.1 Germany
9.3.2 U.K.
9.3.3 France
9.3.4 Rest of Europe
9.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Rest of Asia Pacific
9.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
9.5.1 Brazil
9.5.2 Argentina
9.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025

10 GLOBAL E-CLINICAL SOLUTIONSMARKETCOMPETITIVE LANDSCAPE
10.1 Overview
10.2 Company Market Share
10.3 Vendor Landscape
10.4 Key Development Strategies

11 COMPANY PROFILES
11.1 Oracle Corporation
11.1.1 Overview
11.1.2 Financial Performance
11.1.3 Product Outlook
11.1.4 Key Developments

11.2 Medidata Solutions, Inc.
11.2.1 Overview
11.2.2 Financial Performance
11.2.3 Product Outlook
11.2.4 Key Developments

11.3 Parexel International Corporation
11.3.1 Overview
11.3.2 Financial Performance
11.3.3 Product Outlook
11.3.4 Key Developments

11.4 Bioclinica, Inc. (A Subsidiary of Cinven)
11.4.1 Overview
11.4.2 Financial Performance
11.4.3 Product Outlook
11.4.4 Key Developments

11.5 Datatrak International, Inc.
11.5.1 Overview
11.5.2 Financial Performance
11.5.3 Product Outlook
11.5.4 Key Developments

11.6 CRF Health
11.6.1 Overview
11.6.2 Financial Performance
11.6.3 Product Outlook
11.6.4 Key Developments

11.7 ERT Clinical
11.7.1 Overview
11.7.2 Financial Performance
11.7.3 Product Outlook
11.7.4 Key Developments

11.8 Merge Healthcare Incorporated
11.8.1 Overview
11.8.2 Financial Performance
11.8.3 Product Outlook
11.8.4 Key Developments

11.9 Omnicomm Systems, Inc.
11.9.1 Overview
11.9.2 Financial Performance
11.9.3 Product Outlook
11.9.4 Key Development

11.10 Maxisit Inc.
11.10.1 Overview
11.10.2 Financial Performance
11.10.3 Product Outlook
11.10.4 Key Development

11.11 Bio-Optronics, Inc.
11.11.1 Overview
11.11.2 Financial Performance
11.11.3 Product Outlook
11.11.4 Key Development

11.12 Eclinical Solutions, LLC.
11.12.1 Overview
11.12.2 Financial Performance
11.12.3 Product Outlook
11.12.4 Key Development

12 Appendix
12.1 Related Reports